White Muscle Disease (selenium/vitamin E deficiency)

White muscle disease is a degenerative condition affecting skeletal and cardiac muscle in young livestock, caused by deficiency of selenium and/or vitamin E in the diet. This nutritional myopathy occurs most commonly in calves, lambs, and kids, though it can affect virtually any animal species when these essential nutrients are inadequate. The disease derives its common name from the characteristic pale, whitish appearance of affected muscle tissue on gross examination, reflecting the replacement of normal muscle fibers with fibrous tissue and calcium deposits. White muscle disease remains an important cause of morbidity and mortality in livestock production systems worldwide, particularly in geographic regions with selenium-deficient soils.

The condition affects young, rapidly growing animals most severely because of their high metabolic demands and limited body reserves of selenium and vitamin E. Calves are typically affected from birth through several months of age, with peak incidence during the first weeks of life. Lambs and kids show similar patterns, often presenting shortly after birth or following periods of rapid growth or stress. The disease also occurs in older animals under certain conditions but is less common and typically less severe than in neonates and juveniles. Prevalence varies dramatically by geographic location, correlating closely with soil selenium content and consequent levels in locally produced feeds.

The impact of white muscle disease on livestock operations includes direct losses from mortality and indirect losses from reduced growth rates, treatment costs, and management complications. Mortality rates in untreated animals with cardiac involvement can exceed fifty percent, while even milder cases result in setbacks to growth and development. The welfare implications are significant, as affected animals experience muscle weakness, pain, and difficulty performing normal activities. Economic analyses consistently demonstrate that prevention through appropriate selenium and vitamin E supplementation costs far less than treating affected animals or absorbing associated losses.

Early recognition and treatment dramatically improve outcomes in white muscle disease, particularly for animals with primarily skeletal muscle involvement. However, cardiac involvement carries a more guarded prognosis regardless of treatment timing. Understanding the geographic distribution of selenium-deficient soils, recognizing clinical signs promptly, and implementing appropriate prevention protocols are essential components of managing this condition in vulnerable livestock populations. The relationship between soil chemistry, plant nutrient content, and animal health illustrates the complex connections between environmental factors and livestock production.

The primary cause of white muscle disease is nutritional deficiency of selenium, vitamin E, or both. These nutrients work synergistically in antioxidant defense systems that protect cells from oxidative damage caused by free radicals and reactive oxygen species. Selenium serves as a cofactor for glutathione peroxidase, an enzyme that neutralizes hydrogen peroxide and lipid hydroperoxides within cells. Vitamin E functions as a fat-soluble antioxidant that interrupts lipid peroxidation chain reactions in cell membranes. When either or both nutrients are deficient, oxidative damage accumulates in metabolically active tissues, with skeletal and cardiac muscle being particularly vulnerable due to their high oxygen consumption and metabolic rates.

Selenium deficiency in livestock results primarily from inadequate selenium content in feedstuffs grown on selenium-deficient soils. Soil selenium distribution varies dramatically across geographic regions, with many areas having levels too low to produce feeds containing adequate selenium for livestock. The Pacific Northwest, Northeast, and Great Lakes regions of North America are well-documented selenium-deficient areas, as are portions of Europe, Australia, New Zealand, and other regions worldwide. Selenium uptake by plants depends on both total soil selenium and various soil chemistry factors affecting its bioavailability. Crops and forages grown on deficient soils may contain less than 0.05 parts per million selenium, well below the 0.1 to 0.3 parts per million considered adequate for livestock.

Vitamin E deficiency occurs through several mechanisms related to feed quality and storage. Vitamin E content is highest in fresh green forages and decreases substantially during hay curing, ensiling, and storage. Extended storage of grains and other feedstuffs similarly reduces vitamin E levels through oxidation. High dietary fat content, particularly unsaturated fats, increases vitamin E requirements by providing more substrate for lipid peroxidation. Competition from other fat-soluble vitamins may affect vitamin E absorption and utilization. Young animals dependent on milk from dams with marginal vitamin E status may not receive adequate amounts through nursing.

Risk factors beyond direct nutrient deficiency influence white muscle disease development. Rapid growth increases metabolic demands and oxidative stress, explaining the predilection for young, fast-growing animals. Stress from weaning, handling, transport, or adverse weather increases oxidative burden and may precipitate clinical disease in animals with marginal status. Exercise and exertion similarly increase muscle oxidative metabolism and can trigger acute episodes of myodegeneration. Cold stress in neonates increases metabolic rate and energy demands. Dam nutritional status during gestation determines offspring selenium and vitamin E stores at birth, with deficient dams producing deficient offspring.

The pathophysiology of white muscle disease involves progressive oxidative damage to muscle cell membranes and intracellular components. Without adequate antioxidant protection, lipid peroxidation damages cell membranes, impairing their structural integrity and function. Mitochondrial damage impairs energy production essential for muscle contraction. Calcium homeostasis is disrupted as damaged membranes fail to maintain normal ion gradients, leading to excessive intracellular calcium accumulation that activates degradative enzymes and causes further cellular injury. The characteristic gross and microscopic changes reflect muscle fiber necrosis, inflammation, and replacement with fibrous tissue and mineral deposits in severely affected areas.

Early warning signs of white muscle disease often develop suddenly in previously healthy-appearing young animals. Affected animals may show initial reluctance to rise, stiffness when moving, or difficulty keeping up with dams or flockmates. Decreased nursing vigor or reduced suckling may be noted in neonates. Mild cases may present with subtle gait abnormalities or reluctance to move that could be attributed to other causes. Animals may appear hunched or have an arched back stance. Trembling or shaking when standing suggests muscle weakness or fatigue. These early signs may be transient or intermittent, potentially delaying recognition of the underlying problem.

As white muscle disease progresses, skeletal muscle involvement becomes increasingly apparent. Affected animals develop pronounced stiffness and weakness, particularly affecting the limbs and back. The characteristic stiff gait with reluctance to flex joints has led to the common name stiff lamb disease in sheep. Animals may be unable to rise without assistance or may rise only on their forelimbs, leaving the hindquarters down. Complete inability to stand develops in severe cases. Muscle swelling may be palpable, particularly in the thigh and shoulder regions, though muscle wasting develops in more chronic cases. Animals may vocalize from discomfort when handled or during attempts to move.

Cardiac involvement produces a distinctly different clinical presentation that may occur separately from or concurrently with skeletal muscle signs. Animals with cardiac white muscle disease may be found dead without premonitory signs, often shortly after exertion or stress. Those discovered alive typically show respiratory distress, rapid and labored breathing, and may have frothy fluid at the nostrils. Elevated heart rate and irregular cardiac rhythm may be detected on auscultation. Weakness and collapse, particularly following exertion, suggest cardiac compromise. Sudden death during handling, vaccination, or other routine procedures may be the first indication of cardiac involvement in an animal or group.

Behavioral changes accompany the physical manifestations of white muscle disease. Affected animals become depressed and withdrawn, showing decreased interest in their surroundings. Nursing behavior decreases or ceases, leading to dehydration and weight loss that compounds the primary problem. Separation from dams or the group occurs as affected animals cannot keep up with normal movement patterns. Animals may stand apart or lie alone rather than engaging in normal social behaviors. The pain and weakness associated with myodegeneration clearly affect quality of life and normal behavioral expression.

Symptom progression varies depending on the severity and distribution of muscle involvement. Mild cases affecting limited muscle groups may show minimal progression and can respond well to treatment. Moderate cases with widespread skeletal muscle involvement progress over days to complete recumbency if untreated. Cardiac involvement may cause rapid deterioration and death within hours of the first observed signs. Animals with both skeletal and cardiac involvement face the worst prognoses. Secondary complications including aspiration pneumonia, pressure sores, and dehydration develop in recumbent animals and contribute to mortality.

Emergency symptoms requiring immediate intervention include complete inability to rise, respiratory distress, irregular heartbeat, and collapse following exertion. These signs indicate severe disease with potential cardiac involvement that may be life-threatening. Any young animal in a known selenium-deficient area showing weakness or stiffness should be considered a potential white muscle disease case requiring prompt evaluation. Groups of affected animals indicate herd or flock-level deficiency requiring immediate supplementation of at-risk individuals along with treatment of clinical cases.

Clinical examination provides the foundation for white muscle disease diagnosis based on characteristic findings in young animals from appropriate geographic or nutritional backgrounds. The combination of weakness, stiffness, and muscle involvement in calves, lambs, or kids from selenium-deficient regions creates a suggestive clinical picture. Physical examination should assess muscle tone and mass, gait and weight-bearing ability, cardiac rate and rhythm, and respiratory function. Firm or swollen muscles may be palpable in acute cases, while atrophy suggests more chronic involvement. Auscultation may reveal cardiac arrhythmias or murmurs when the heart is affected. The signalment and history of dietary management provide important context for interpreting clinical findings.

Laboratory testing confirms white muscle disease diagnosis and helps differentiate it from other causes of similar clinical signs. Serum muscle enzyme levels, particularly creatine kinase and aspartate aminotransferase, are markedly elevated in animals with active muscle necrosis, often reaching levels ten to one hundred times normal values. These enzymes provide sensitive markers of myodegeneration but are not specific to white muscle disease. Blood selenium levels below 0.05 parts per million strongly suggest deficiency, with levels between 0.05 and 0.08 considered marginal. Glutathione peroxidase activity in red blood cells provides an integrated measure of longer-term selenium status. Vitamin E levels can be measured but are less routinely performed than selenium testing.

Differential diagnosis must consider other conditions causing weakness, stiffness, or sudden death in young livestock. Infectious myositis from clostridial organisms causes muscle swelling and may initially resemble white muscle disease but typically produces fever, toxemia, and gas in affected tissues. Trauma and overexertion can cause muscle damage and elevated enzymes but usually have identifiable precipitating events. Joint and bone diseases cause lameness that might be confused with muscle stiffness. Cardiac abnormalities from other causes must be differentiated when sudden death occurs. Tetanus produces muscle rigidity but with characteristic tetanic spasms and history of wound contamination. Electrolyte imbalances can cause weakness and collapse requiring biochemistry evaluation.

Necropsy examination provides definitive diagnosis through demonstration of characteristic gross and microscopic lesions. Affected skeletal muscles show pale, white, or chalky streaks and patches, most prominently in the muscles of the thigh, shoulder, and diaphragm. The heart may show similar pale areas, particularly in the ventricular myocardium and interventricular septum. Histopathological examination reveals muscle fiber necrosis with characteristic Zenker's degeneration, inflammatory cell infiltration, and mineral deposition. These findings combined with low tissue selenium levels confirm the diagnosis. Necropsy of animals that die during outbreaks enables definitive diagnosis and helps guide prevention efforts for remaining animals at risk.

Emergency treatment of white muscle disease centers on immediate selenium and vitamin E supplementation. Injectable preparations containing both nutrients are available and should be administered as soon as the condition is suspected. Dosages vary by species and product formulation, but typical recommendations include one milligram of selenium per forty-five kilograms of body weight for cattle and proportionally adjusted doses for smaller ruminants. Both intramuscular and subcutaneous routes are used depending on product labeling. Initial treatment should be followed by repeat administration at intervals specified by the veterinarian, typically at one to four week intervals. Oral selenium supplementation is also effective and may be used following injectable loading doses.

Vitamin E supplementation should accompany selenium treatment because the two nutrients work synergistically and deficiency of both may be present. Injectable vitamin E preparations provide rapid restoration of tissue levels. Oral vitamin E supplementation can follow injectable treatment for ongoing maintenance. The combination of selenium and vitamin E addresses both components of the antioxidant system disrupted in white muscle disease. Some commercial products combine both nutrients in single injectable preparations for convenience. Adequate vitamin E status also helps protect against further oxidative damage during the recovery period.

Supportive care is essential for animals with significant muscle damage or recumbency. Anti-inflammatory medications help manage pain and reduce secondary inflammation in damaged muscle tissue. Affected animals should be maintained on soft, clean bedding to prevent pressure sores and secondary injuries. Recumbent animals should be turned regularly and assisted to sternal recumbency to prevent respiratory complications. Nutritional support through bottle feeding, tube feeding, or intravenous fluids maintains hydration and energy balance in animals that cannot nurse normally. Protection from environmental extremes reduces additional metabolic stress.

Cardiac involvement significantly complicates treatment and requires modified management approaches. Animals with cardiac white muscle disease should be handled minimally and kept as quiet as possible to reduce cardiac workload. Stress from handling, transport, or excitement may precipitate sudden death in animals with compromised heart function. Anti-arrhythmic medications may be considered in valuable animals with documented cardiac irregularities, though their efficacy in this context is not well established. The prognosis for animals with significant cardiac involvement is guarded regardless of treatment intensity, and owners should be counseled appropriately.

Herd or flock-level treatment may be indicated when multiple animals are affected or at risk. All young animals in the same management group as affected individuals should receive prophylactic selenium and vitamin E supplementation, as they share the same deficient nutritional background. Pregnant and lactating dams should be supplemented to improve status for subsequent offspring. Review and correction of the nutritional program to provide adequate selenium and vitamin E prevents ongoing cases. Testing of feeds and forages documents deficiency and guides supplementation strategies.

Treatment decisions involve consideration of both prognosis and economics. Animals with mild skeletal muscle involvement treated promptly have excellent recovery potential. Those with severe, widespread myodegeneration may survive but have extended recovery periods and possible permanent muscle damage affecting productivity. Cardiac involvement carries substantial mortality risk, and aggressive treatment may not prevent death. The costs of intensive nursing care must be weighed against recovery likelihood and the animal's value. Humane euthanasia may be appropriate for animals with poor prognoses, particularly those with severe cardiac involvement or prolonged recumbency.

Recovery from white muscle disease depends critically on the extent and distribution of muscle damage and whether cardiac involvement is present. Animals with mild, localized skeletal muscle involvement may show improvement within days of selenium and vitamin E supplementation, with return of normal muscle function over one to three weeks. More severely affected animals require longer recovery periods, potentially extending over several months for regeneration of significantly damaged muscle tissue. Cardiac muscle has limited regenerative capacity compared to skeletal muscle, so animals with cardiac involvement may retain permanent functional deficits even if they survive the acute episode.

Post-treatment care and monitoring support recovery and prevent relapse. Continued selenium and vitamin E supplementation maintains antioxidant protection during the recovery period when damaged tissues are particularly vulnerable to oxidative stress. Activity should be restricted initially and gradually increased as muscle function improves, with careful observation for signs of fatigue or weakness that might indicate residual damage or cardiac involvement. Nutritional support ensures adequate protein and energy for muscle repair and regeneration. Follow-up veterinary examination helps assess progress and identify any complications requiring additional intervention.

Prognostic factors help predict outcomes and guide management decisions. The extent of muscle damage at diagnosis significantly influences prognosis, with mild cases carrying much better outlooks than severe, widespread myodegeneration. Cardiac involvement worsens prognosis substantially, and animals with documented cardiac lesions or arrhythmias have guarded outcomes regardless of treatment. Response to initial treatment, assessed by improvement in mobility and normalization of muscle enzymes over the first few days, provides useful prognostic information. Young age generally favors recovery due to the greater regenerative capacity of juvenile tissues.

Return to production following white muscle disease recovery varies by species and production type. Calves that recover fully can typically return to normal growth trajectories and productive functions. However, some animals may have reduced growth rates or productivity compared to unaffected contemporaries, reflecting permanent muscle damage or developmental setbacks during the illness period. Animals recovered from cardiac involvement should be considered at risk for sudden death during stress or exertion indefinitely and may be inappropriate for demanding production roles. Breeding decisions should consider that offspring of recovered animals will require selenium supplementation appropriate to their deficient environment rather than any concern about genetic transmission of the condition.

Prevention of white muscle disease through appropriate selenium and vitamin E supplementation is highly effective and economically favorable compared to treatment of clinical cases. Selenium supplementation can be provided through multiple routes including injectable preparations, oral drenches, feed additives, mineral supplements, and slow-release boluses. Injectable selenium, typically provided to pregnant dams one to four weeks before parturition, ensures adequate selenium status in newborns during their highest-risk period. Oral selenium supplementation in feed or mineral form provides ongoing availability for all animals with access. Slow-release selenium boluses provide extended supplementation with single administration.

Maternal supplementation during pregnancy is particularly important for preventing neonatal white muscle disease. Selenium crosses the placenta and is incorporated into fetal tissues during development, so selenium-adequate dams produce selenium-adequate offspring. Supplementation of pregnant dams during the last trimester builds fetal reserves for the neonatal period before offspring begin consuming solid feeds. Adequate maternal vitamin E status similarly benefits offspring through milk vitamin E content and possibly placental transfer. Dam supplementation programs should begin well before parturition to ensure adequate tissue levels.

Feed and forage management influences selenium and vitamin E availability throughout the production year. Understanding local soil selenium status helps predict feedstuff selenium content and supplementation needs. Feed testing documents actual selenium and vitamin E levels, enabling rational supplementation rather than guesswork. Vitamin E content declines during harvest and storage, so fresh or well-preserved feeds provide higher levels than old or improperly stored feeds. Limiting the storage duration of feeds preserves vitamin E potency. Selenium-fertilized pastures provide another approach in some management systems, though regulatory restrictions apply in some jurisdictions.

Mineral supplementation programs provide a practical approach to selenium delivery for grazing animals. Free-choice minerals containing selenium allow animals to self-regulate intake based on physiological needs. Mineral formulations should be appropriate for the species and production stage, with selenium levels calculated to provide adequate intake based on expected consumption rates. Palatability affects mineral consumption, so formulations should be well-accepted by the target animals. Mineral feeder placement and protection from weather influences consumption and should be managed for consistent access. Monitoring mineral disappearance helps confirm adequate consumption by the group.

Monitoring programs validate prevention effectiveness and identify needed adjustments. Periodic blood selenium testing of representative animals documents population status and confirms supplementation adequacy. Glutathione peroxidase activity provides a more stable measure of longer-term status than serum selenium. Testing should target highest-risk groups including young animals and pregnant females. Any cases of white muscle disease despite supplementation indicate inadequate delivery or dosing requiring program modification. Record keeping of supplementation practices and any disease cases enables continuous improvement in prevention strategies.

Daily management of livestock in selenium-deficient regions requires ongoing attention to mineral nutrition and health monitoring. Young animals should be observed daily for any signs of stiffness, weakness, or reluctance to move that might indicate developing white muscle disease. Activity levels, nursing behavior, and growth should be monitored as indicators of overall health and nutritional adequacy. Animals failing to keep up with contemporaries warrant closer evaluation. Feed and mineral consumption should be assessed regularly to confirm that supplementation is reaching all animals in the group.

Housing and environmental management influence white muscle disease risk through their effects on stress and metabolic demands. Cold stress in neonates increases oxidative metabolism and white muscle disease risk, so appropriate protection from severe weather is important in vulnerable populations. Adequate space reduces competition that might limit mineral supplement access for subordinate animals. Clean, dry bedding supports health and reduces additional metabolic burdens from fighting infection or maintaining body temperature. Facility design should ensure that mineral feeders are accessible to all animals including young stock.

Supplementation delivery systems must be designed for the specific operation and species involved. Free-choice minerals require appropriate feeder design and placement for target species access. Salt and mineral mixes should be palatable and properly formulated for selenium content and consumption rate. Water-based selenium delivery may be appropriate in some systems. Injectable programs require scheduling and labor planning for timely administration. Multiple delivery methods may be combined to ensure adequate coverage across all animal classes and production stages.

Record keeping supports effective white muscle disease prevention over time. Supplementation records should document products used, application dates, and animals or groups treated. Any cases of white muscle disease should be recorded with full details enabling pattern identification. Laboratory results including blood selenium testing should be maintained and reviewed periodically. Feed test results document selenium and vitamin E content of ration components. This information enables refinement of prevention strategies and provides documentation for veterinary consultation.

Economic considerations support investment in white muscle disease prevention. The costs of supplementation programs are modest compared to losses from clinical disease, reduced growth, and mortality. Economic analysis comparing prevention costs to expected losses without prevention typically shows favorable returns on supplementation investment. Labor costs for monitoring and injectable supplementation programs should be factored into planning. The intangible costs of animal suffering and welfare compromise also support prevention over treatment approaches.

White muscle disease can affect all livestock breeds when selenium and vitamin E nutrition is inadequate, with risk determined primarily by geographic location and management practices rather than genetics. However, certain breed and production characteristics influence the likelihood of clinical disease development. Rapidly growing breeds and individuals face higher risk because their intense metabolic activity increases oxidative stress and antioxidant demands. Double-muscled cattle breeds may be more susceptible due to their enhanced muscle mass and metabolic requirements. Highly productive dairy breeds have elevated metabolic demands that may increase vitamin E and selenium requirements beyond those of less intensively selected animals.

Production type significantly influences white muscle disease risk across species. Beef calves born on pasture in selenium-deficient regions face high risk, particularly when dams have not been supplemented. Dairy calves raised in confinement may have different risk profiles depending on colostrum and milk selenium content from supplemented or unsupplemented dams. Feedlot cattle typically receive selenium-fortified rations but may develop the condition during the transition period following arrival. Sheep and goat operations in deficient areas commonly experience white muscle disease in lambs and kids, with meat-type animals potentially at higher risk than fiber-producing breeds due to more rapid growth rates.

Species considerations affect white muscle disease patterns and prevention approaches. Cattle appear somewhat more tolerant of marginal selenium status than sheep, though clinical disease occurs in both species when deficiency is severe. Sheep and goats may be more sensitive to vitamin E deficiency independent of selenium status. Pigs develop selenium deficiency syndromes including hepatosis dietetica and mulberry heart disease that share pathophysiological features with ruminant white muscle disease. Poultry experience nutritional myopathy and encephalomalacia from vitamin E deficiency. Understanding species-specific susceptibility patterns guides prevention strategies in diversified operations or when information must be extrapolated across species.

Several conditions commonly occur alongside or share features with white muscle disease. Selenium deficiency causes additional syndromes beyond white muscle disease that may occur concurrently or independently. Ill-thrift and impaired immune function are associated with subclinical selenium deficiency and may be present in animals that have not developed overt myopathy. Retained placenta and metritis in postpartum cattle correlate with selenium deficiency and may affect dams of white muscle disease-affected calves. Impaired fertility and early embryonic death have been associated with selenium deficiency in some studies. These related manifestations of selenium deficiency often improve with supplementation alongside white muscle disease prevention.

Conditions producing similar clinical signs must be differentiated from white muscle disease for appropriate treatment. Clostridial myositis including blackleg causes muscle swelling and sudden death but typically produces fever, gas in tissues, and characteristic lesions distinct from white muscle disease. Traumatic muscle injuries may cause lameness and elevated muscle enzymes but usually have identifiable precipitating events. Congenital contracture and other developmental orthopedic conditions may resemble white muscle disease in neonates but lack the muscle enzyme elevations and response to selenium supplementation. Tetanus produces muscle rigidity but with tetanic spasms and history of wound contamination. Cardiac anomalies from other causes may produce sudden death requiring necropsy differentiation.

Complications and sequelae of white muscle disease extend the condition's impact. Secondary infections may develop in weakened or recumbent animals, including aspiration pneumonia from impaired swallowing function. Pressure sores and myopathy from recumbency add to muscle damage in prolonged cases. Dehydration and malnutrition develop in animals unable to nurse or access feed and water normally. Permanent cardiac damage in survivors of cardiac white muscle disease may limit exercise tolerance and stress handling indefinitely. Growth setbacks during the illness period may not be fully compensated, affecting lifetime productivity. These complications emphasize the importance of prevention and early treatment rather than management of advanced disease.